Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
(NASDAQ: CRVS) Delayed: 14.39 --0 (-0%)
Previous Close $14.39    52 Week High $17.77 
Open $14.39    52 Week Low $9.63 
Day High $14.39    P/E N/A 
Day Low $14.39    EPS $0.00 
Volume 120